PepperLime Health Acquisition Overview
PepperLime Health Acquisition (PEPL) has a ROE of 91.4%, above the sector sector average of 11.64%.
Get informed when a big investor buys or sells
+ Follow91.40%
Return on Equity measures how efficiently a company uses shareholders' equity to generate profits. A higher ROE indicates better profitability relative to equity.
PepperLime Health Acquisition posts a ROE of 91.4%. That is above the sector sector average of 11.64%. Comparing that reading with peers and prior periods is usually more useful than looking at the number in isolation.
For its sector stocks, a ROE near 11.64% is typical. PepperLime Health Acquisition's 91.4% is higher that level. That is roughly 685.4% above the sector mean. Whether that is a warning or an opportunity depends on growth outlook and other fundamentals shown elsewhere on Stockcircle.
PepperLime Health Acquisition's ROE moves when the underlying profit, equity, or asset base changes. Cost cuts, pricing power, buybacks, write-downs, and cyclical swings can all shift the percentage. The latest reading is 91.4%; use YoY and peer views to separate noise from signal.
Context for PEPL's ROE usually means three checks: (1) trend versus prior periods, (2) level versus peers (average 11.64%), and (3) consistency with growth and profitability. This page covers the first two; PepperLime Health Acquisition's other metric pages and overview cover the third.
